Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Pouget

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Radiopharmaceutical Therapy Meets Radiobiology: Implications for Trial Design and DNA Repair Inhibitor CombinationsKatharina Lückerath, Pablo Mínguez Gabiña, Uta Eberlein, et al.
Plos One|June 13, 2015
Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin LymphomaAda H V Repetto-Llamazares, Roy H Larsen, Sebastian Patzke, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|March 5, 2004
Radiation-induced DNA damage: formation, measurement, and biochemical featuresJean Cadet, Sophie Bellon, Thierry Douki, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 11, 2025
Methodology for comparing absorbed dose rate calculation algorithms in molecular radiotherapy dosimetryJosé-Alejandro Fragoso-Negrín, Lore Santoro, Kevin Hébert, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic miceChristel Larbouret, Bruno Robert, Christine Linard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosisLore Santoro, Samir Boutaleb, Véronique Garambois, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2024
Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using PretargetingSophie Poty, Laura Ordas, Yana Dekempeneer, et al.
Nuclear Medicine and Biology|March 26, 2013
Apoptosis and p53 are not involved in the anti-tumor efficacy of ¹²⁵I-labeled monoclonal antibodies targeting the cell membraneSalomé Paillas, Vincent Boudousq, Bérengère Piron, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [<sup>177</sup>Lu]Lu-DOTATATE: One Step Closer to Personalized MedicineKévin Hebert, Lore Santoro, Maeva Monnier, et al.
Radiation Research|August 1, 2008
Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electronsJean-Pierre Pouget, Lore Santoro, Laure Raymond, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Radiopharmaceutical Therapy Meets Radiobiology: Implications for Trial Design and DNA Repair Inhibitor CombinationsKatharina Lückerath, Pablo Mínguez Gabiña, Uta Eberlein, et al.
Plos One|June 13, 2015
Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin LymphomaAda H V Repetto-Llamazares, Roy H Larsen, Sebastian Patzke, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|March 5, 2004
Radiation-induced DNA damage: formation, measurement, and biochemical featuresJean Cadet, Sophie Bellon, Thierry Douki, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 11, 2025
Methodology for comparing absorbed dose rate calculation algorithms in molecular radiotherapy dosimetryJosé-Alejandro Fragoso-Negrín, Lore Santoro, Kevin Hébert, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic miceChristel Larbouret, Bruno Robert, Christine Linard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosisLore Santoro, Samir Boutaleb, Véronique Garambois, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2024
Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using PretargetingSophie Poty, Laura Ordas, Yana Dekempeneer, et al.
Nuclear Medicine and Biology|March 26, 2013
Apoptosis and p53 are not involved in the anti-tumor efficacy of ¹²⁵I-labeled monoclonal antibodies targeting the cell membraneSalomé Paillas, Vincent Boudousq, Bérengère Piron, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [<sup>177</sup>Lu]Lu-DOTATATE: One Step Closer to Personalized MedicineKévin Hebert, Lore Santoro, Maeva Monnier, et al.
Radiation Research|August 1, 2008
Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electronsJean-Pierre Pouget, Lore Santoro, Laure Raymond, et al.
Pageof 7